Background: Olfactory dysfunction is common in Parkinson’s disease (PD). The characteristics of the hyposmia in PD have not been well defined. Objective: To characterize the pattern of the olfactory deficit in PD and in other non-neurodegenerative aetiologies of hyposmia. Methods: We evaluated 36 PD patients, 20 patients with hyposmia secondary to acute respiratory infection (ARI), and 19 patients with hyposmia secondary to traumatic brain injury (TBI). For comparison purposes, we included a group of 15 controls age and sex matched with PD patients. PD patients were classified based on disease duration and severity in de novo PD, and PD with and without chronic levodopa-related complications. The Barcelona Smell Identification Test was applied to all participants. Results: For the first cranial nerve odours, PD patients scored lower than controls on smell detection (85.28 vs. 97.67%, p = 0.006), definition (79.58 vs. 93.33%, p = 0.007), recognition (63.33 vs. 81%, p = 0.020), and forced choice (58.06 vs. 82%, p < 0.001). Compared with ARI, forced choice was significantly better in PD patients (p < 0.001), but no differences were found regarding other olfactory characteristics. TBI patients showed significantly lower scores than the other study groups in all the olfaction items. For the fifth cranial nerve odours, recognition (p = 0.003) and identification (p = 0.019) were lower in the TBI group than in the others. No differences were found among PD subgroups regarding any olfactory characteristic. Conclusions: A differential pattern of hyposmia was observed in PD patients compared to other non-neurodegenerative aetiologies. Further studies with larger samples should replicate our results.

Keywords:
Parkinson’s disease, Olfaction, Hyposmia
1.
Muller A, Reichmann H, Livermore A, Hummel T: Olfactory function in idiopathic Parkinson’s disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Transm 2002; 109: 805–811.
2.
Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI: Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1992; 55: 138–142.
3.
Tissingh G, Berendse HW, Bergmans P, et al: Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord 2001; 16: 41–46.
4.
Buck L: Smell and taste: the chemical senses; in Kandel E, Schwartz J, Jessell T (eds): Principles of Neural Science, ed 4. New York, McGraw-Hill Medical, 2000, pp 625–635.
5.
Lundstrom JN, Boesveldt S, Albrecht J: Central processing of the chemical senses: an overview. ACS Chem Neurosci 2011; 2: 5–16.
6.
Landis BN, Konnerth CG, Hummel T: A study on the frequency of olfactory dysfunction. Laryngoscope 2004; 114: 1764–1769.
7.
Fonteyn S, Huart C, Deggouj N, Collet S, Eloy P: Non-sinonasal-related olfactory dysfunction: a cohort of 496 patients. Rombaux Eur Ann Otorhinolaryngol Head Neck Dis 2014; 131: 87–91.
8.
Braak H, del Tredici K, Rub U, de Vos AI, Jansen Steur ENH, Braak E: Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003; 24: 197–211.
9.
Saito Y, Shioya A, Sano T, Sumikura H, Murata M, Murayama S: Lewy body pathology involves the olfactory cells in Parkinson’s disease and related disorders. Mov Disord 2016; 31: 135–138.
10.
Cardesin A, Alobid I, Benitez P, et al: Barcelona Smell Test-24 (BAST-24): validation and smell characteristics in the healthy Spanish population. Rhinology 2006; 44: 83–88.
11.
Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181–184.
12.
Goetz CG, Tilley BC, Shaftman SR, et al: Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008; 23: 2129–2170.
13.
Hoehn MM, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–442.
14.
Moller JC, Korner Y, Dodel RC, et al: Pharmacotherapy of Parkinson’s disease in Germany. J Neurol 2005; 252: 926–935.
15.
Hoyles K, Sharma JC: Olfactory loss as a supporting feature in the diagnosis of Parkinson’s disease: a pragmatic approach. J Neurol 2013; 260: 2951–2958.
16.
Schulman LM, Taback RL, Rabinstein AA, Weiner WJ: Nonrecognition of depression and other nonmotor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 2002; 8: 193–197.
17.
Hely MA, Morris JGL, Reid WGJ, Trafficante R: Sydney multicenter study of Parkinson’s disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005; 20: 190–199.
18.
Gaig C, Tolosa E: When does Parkinson’s disease begin? Mov Disord 2009; 24:S656–S664.
19.
Ansari KA, Johnson A: Olfactory function in patients with Parkinson’s disease. J Chronic Dis 1975; 28: 493–497.
20.
Ward CD, Hess WA, Calne DB: Olfactory impairment in Parkinson’s disease. Neurology 1983; 33: 943–946.
21.
Hawkes CH, Shephard BC, Daniel SE: Olfactory dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1997; 62: 436–446.
22.
Potagas C, Dellatolas G, Ziegler M, et al: Clinical assessment of olfactory dysfunction in Parkinson’s disease. Mov Disord 1998; 13: 394–399.
23.
Quinn NP, Rossor MN, Marsden CD: Olfactory threshold in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1987; 50: 88–89.
24.
Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, Moore RY: Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease. J Neurol 2007; 254: 84–90.
25.
Whitcroft KL, Cuevas M, Haehner A, Hummel T: Patterns of olfactory impairment reflect underlying disease etiology. Laryngoscope 2017; 127: 291–295.
26.
Witt M, Bormann K, Gudziol V, Pehlke K, Barth K, Minovi A: Biopsies of olfactory epithelium in patients with Parkinson’s disease. Mov Disord 2009; 24: 906–914.
27.
Saito Y, Shioya A, Sano T, Sumikura H, Murata M, Murayama S: Lewy body pathology involves the olfactory cells in Parkinson’s disease and related disorders. Mov Disord 2016; 31: 135–138.
28.
Kalbe E, Rehberg SP, Heber I, et al: Subtypes of mild cognitive impairment in patients with Parkinson’s disease: evidence from the LANDSCAPE study. J Neurol Neurosurg Psychiatry 2016; 87: 1099–1105.
29.
Price SE, Kinsella GJ, Ong B, et al: Learning and memory in amnestic mild cognitive impairment: contribution of working memory. J Int Neuropsychol Soc 2010; 16: 342–351.
30.
Sigurdardottir S, Jerstad T, Andelic N, et al: Olfactory dysfunction, gambling task performance and intracranial lesions after traumatic brain injury. Neuropsychology 2010; 24: 504–513.
31.
Haxel BR, Grant L, Mackay-Sim A: Olfactory dysfunction after head injury. J Head Trauma Rehabil 2008; 23: 407–413.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.